Mud Therapy
Conditions
Keywords
mud therapy, natural mineral water, barium, poultices, skin transfer
Brief summary
It involves conducting a clinical study on a population of healthy volunteers (age between 18 and 30 years) without direct benefit for the subject to explore a transfer of barium in the blood and urine following applications of thermal mud. The main objective is to highlight an increase in serum barium level of at least twice.
Detailed description
The presence of barium in thermal clays was noted by the ARS (french administration) who interviewed the Directorate General of Health (DGS); the latter seized the National Academy of Medicine (June 2016) which reported in February 2017. In this report it was stated that there was no argument in favor of toxic phenomena related to the presence of barium but that it was appropriate, in particular, to evaluate a possible passage of barium in the skin in subjects who are treated with thermal mud * by observing, where appropriate, an increase in serum and urinary barium levels in the subjects concerned and * by measuring a possible depletion of barium in the sludge used. The DGS validated the various recommendations of the Academy and asked, in January 2018, the National Council of Thermal Establishments (CNETH) to implement the recommendations of the Academy. It will therefore be a prospective before-after interventional study, implementing 15 daily applications of 6 mud poultices made with a clay used as thermal clay and containing appreciable barium levels. A surveillance will be put in place with the event of suspected event, the volunteer can then be seen by a doctor.
Interventions
OTHERMud therapy
Application of sludge poultice
Sponsors
Association Francaise pour la Recherche Thermale
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* volunteers, healthy (without known and / or treated disease) * 18 to 30 years old, * men and women, who can give their informed consent, presenting the elements of cutaneous and general tolerance of sludge applications * patient affiliated to a social security scheme
Exclusion criteria
* subject who can not give informed consent * pregnant woman ; woman of childbearing years not wishing to have contraception available for the duration of the trial * subject to a legal protection measure or a judicial review, subject having a known allergy to a heavy metal, a BMI greater than 30 * a characterized contact eczema, an active dermatosis, an acute affection, a disorder of the cutaneous sensitivity, an intolerance to the heat * heart, kidney or lung disease that may be decompensated with the use of hot products * a progressive disease (inflammatory, infectious or tumoral) potentially liable to worsen with the application of thermal physical agents
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of the plasma level of barium | 3 weeks | Plasma level of barium |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of the urinary rate of barium | 3 weeks | Urinary rate of barium |
| Plasma level of barium exceeds the level deemed tolerable by INRS (French Institute for Research and Security) | 3 weeks | plasma levels of barium |
| Number of patients who doubles the urinary and plasma level of barium | 3 weeks | plasma and urinary levels of barium |
Countries
France
Contacts
Primary ContactJerome Dimet, PhD
Backup ContactAnne-Hélène Boivin
Outcome results
None listed